OWC Pharmaceutical Research Corp
OWC Pharmaceutical Research Corp., through its subsidiary, One World Cannabis Ltd., engages in the research and development of cannabis-based medical products. It develops cannabis-based medical products for the treatment of various conditions, including multiple myeloma, psoriasis, post-traumatic stress disorder, chronic pain, and fibromyalgia. The company is also involved in developing cannabis… Read more
OWC Pharmaceutical Research Corp (OWCP) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2019: 0.093x
Based on the latest financial reports, OWC Pharmaceutical Research Corp (OWCP) has a cash flow conversion efficiency ratio of 0.093x as of September 2019.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-372.00K) by net assets ($-4.01 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
OWC Pharmaceutical Research Corp - Cash Flow Conversion Efficiency Trend (2008–2018)
This chart illustrates how OWC Pharmaceutical Research Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
OWC Pharmaceutical Research Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of OWC Pharmaceutical Research Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ELQ Spolka Akcyjna
F:7DP
|
N/A |
|
FLOWTECH FLUIDPOWER LS-50
F:2FW
|
N/A |
|
PCI-PAL PLC
LSE:PCIP
|
-0.753x |
|
Polygreen Resources Co., Ltd.
TWO:8423
|
N/A |
|
HAD
VN:HAD
|
N/A |
|
KASATI
VN:KST
|
N/A |
|
Perk International Inc
PINK:PRKI
|
0.349x |
|
CHINA COMM SRVCS-H
MU:CMW
|
N/A |
Annual Cash Flow Conversion Efficiency for OWC Pharmaceutical Research Corp (2008–2018)
The table below shows the annual cash flow conversion efficiency of OWC Pharmaceutical Research Corp from 2008 to 2018.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2018-12-31 | $-9.44 Million | $-2.50 Million | 0.265x | +117.65% |
| 2017-12-31 | $790.60K | $-1.19 Million | -1.500x | +71.38% |
| 2016-12-31 | $100.99K | $-529.27K | -5.241x | -39.12% |
| 2015-12-31 | $322.82K | $-1.22 Million | -3.767x | -814.59% |
| 2014-12-31 | $1.46 Million | $-602.40K | -0.412x | -156.40% |
| 2013-12-31 | $-125.71K | $-91.80K | 0.730x | +40.80% |
| 2012-12-31 | $-80.26K | $-41.63K | 0.519x | -73.36% |
| 2011-12-31 | $-34.65K | $-67.46K | 1.947x | +425.63% |
| 2008-12-31 | $150.51K | $-89.98K | -0.598x | -- |